Yifan Pharmaceutical Co., Ltd. (002019.SZ)

CNY 11.38

(0.53%)

Market Cap (In CNY)

13.84 Billion

Revenue (In CNY)

4.02 Billion

Net Income (In CNY)

-551.07 Million

Avg. Volume

11.37 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.11-15.39
PE
-44.96
EPS
-0.27
Beta Value
0.965
ISIN
CNE000001K65
CUSIP
-
CIK
-
Shares
1216390000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Xian Feng Cheng
Employee Count
-
Website
https://www.yifanyy.com
Ipo Date
2004-07-13
Details
Yifan Pharmaceutical Co., Ltd. produces and sells drugs and medicines in China and internationally. It provides drugs across gynecology, pediatrics, orthopedics, and dermatology therapeutic areas; therapeutic infusion solutions; and pantothenic acid and Provitamin B5 products. The company also provides Chinese traditional medicines, women's health products, and blood tumor drugs. In addition, it offers APIs, including feed additives/animal health products, skin and hair care ingredients, functional food additives, and fine chemicals; and PBAT/PBS biodegradable resins and PVB films. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is based in Hangzhou, China.

More Stocks